Skip to main content
1100 Industrial Road, Suite 1, San Carlos, CA. 94070

Now, we are currently enrolling patients in our INHERIT trial. Learn more.

Person in ocean
Our Mission

We strive to make lung cancer a survivable disease.

Partnering with the most innovative minds from the world’s premier oncology research institutions, we provide funds, staff, and a team of experts to assist in launching and managing investigator-initiated trials. 

As a 501c(3) nonprofit organization, we’re dedicated to forwarding research that can lead to new therapeutics, diagnostics, and a better understanding of lung cancer risk factors and resistance mechanisms.

null image for spacing
null image for spacing

The ALCMI Approach to Lung Cancer Science

To maximize our impact and investment, we concentrate our research efforts on 5 areas of focus.

INHERIT TRIAL POSTER
null image for spacing

*** Now Enrolling ***

Help us learn more about inherited risk in lung cancer. 

Our current study, INHERIT (Investigating Hereditary Risk in Thoracic Cancers), aims to understand better the genetic risk for developing lung cancer. Partnering with Dana-Farber Cancer Institute and GO2 for Lung Cancer, we're investigating why lung cancer sometimes runs in families. We're looking at genetics as well as environmental factors and how these may interact. We hope this information will ultimately improve lung cancer screening, prevention, and treatment. 

This is just one of the ways we're working to make lung cancer a survivable disease. 

beaker in laboratory
By The Numbers

We invest in lung cancer science.

We're funding critical lung cancer research and providing staffing and guidance to quickly get investigator-initiated trials up and running. 

We're proud of our stats, and we're just getting started.

  • Founded

    2008

  • Completed Clinical Trials

    23

  • Publication Citations and Downloads

    13,659

  • Trial Participants

    1,754

  • Partners and Sponsors

    56

Peer-Reviewed, Published Studies

Our studies have led to numerous publications in the world’s most prestigious peer-reviewed oncology journals.

Dr. Biagio Ricciuti headshot

“My collaboration with ALCMI has been an exceptional experience. Their commitment to advancing lung cancer research is unmatched, and together, we’ve been able to accelerate our understanding of resistance mechanisms to targeted therapies and the development of new therapies for patients in need. ALCMI’s innovative approach and deep expertise have made a significant impact in bridging the gap between research and patient care, offering real hope to those facing lung cancer.”

DR. BIAGIO RICCIUTI, DANA-FARBER CANCER INSTITUTE


Our Consortium Partners

We're proud to join forces with the world's most prestigious oncology research organizations. 


Addario Lung Cancer Medical Institute (ALCMI)
1100 Industrial Road, Suite 1, San Carlos, CA. 94070
MENU CLOSE